The Role of Medical Affairs in Lifecycle Management

As treatments lose exclusivity, biopharma companies are shifting from simply launching generics to strategically extending impact through lifecycle management (LCM). Medical Affairs plays a vital role in this shift—ensuring approved therapies reach broader patient populations beyond initial indications. This article, informed by 21 industry leaders, outlines best practices for effective LCM in maximizing long-term therapeutic and organizational value.